Order Article Reprints

Trafalis DT, Sagredou S, Dalezis P, Voura M, Fountoulaki S, Nikoleousakos N, Almpanakis K, Deligiorgi MV, Sarli V. Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation. Pharmaceutics. 2021; 13(4):493. https://doi.org/10.3390/pharmaceutics13040493

Trafalis, Dimitrios T., Sofia Sagredou, Panayiotis Dalezis, Maria Voura, Stella Fountoulaki, Nikolaos Nikoleousakos, Konstantinos Almpanakis, Maria V. Deligiorgi, and Vasiliki Sarli. 2021. "Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation" Pharmaceutics 13, no. 4: 493. https://doi.org/10.3390/pharmaceutics13040493

Trafalis, D. T., Sagredou, S., Dalezis, P., Voura, M., Fountoulaki, S., Nikoleousakos, N., Almpanakis, K., Deligiorgi, M. V., & Sarli, V. (2021). Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation. Pharmaceutics, 13(4), 493. https://doi.org/10.3390/pharmaceutics13040493